+34 603 445 673 
The Cosmetic Products Regulation (CPR)
The Cosmetic Products Regulation, formerly published as Regulation (EC) 1223/2009, applies to all cosmetic products made available on the EU market. Its main objective is to create a unified legal framework across the EU to protect consumer health by ensuring that all cosmetics meet strict safety requirements before being placed on the market and ensure the functioning of the internal market for cosmetic products.
The revision of the Regulation (EC) 1223/2009
This initiative by the EU Commission will assess whether the rules are working as intended.
It is expected to provide evidence of how the Cosmetic Product Regulation has been applied, whether it has delivered on its objectives and whether it remains fit for purpose, including for the green and digital transitions and the external and internal competitiveness of EU businesses, in the light of current developments.
This first evaluation of the CPR is being carried out 10 years after the Regulation became fully applicable. It is expected to provide insights into how effectively the CPR has been applied, whether it has delivered on its objectives, and if it remains fit for purpose, especially focused on the green and digital transitions and the external and internal competitiveness of EU businesses in the light of current developments.
The evaluation will investigate, among other things, the current scope of Regulation 1223/2009, the definitions used, the application of the generic risk approach to ingredients with potentially higher risk for human health, and labelling provisions, as well as the main trends in international trade and the external competitiveness of the EU industry.
It will explore areas for improvement, including any untapped potential for simplification and burden reduction, and examine whether the CPR is fit to support and enable international convergence with other jurisdictions.
The period covered by the evaluation will be from 2013, when the CPR started to apply in its entirety, until 2024, the last complete period with relevant data. In that period, 50 amendments of the Annexes to the Regulation were made, plus 11 corrections and one amendment modifying Article 2 of the CPR.
What the Commission will consider for the evaluation?
The evaluation will encompass all EU countries and EEA countries. It will cover all CPR provisions, including CPNP and will follow the five evaluation criteria set out in the Better Regulation guidelines:
- Effectiveness: Evaluate the extent to which the Regulation contributed to protecting human health while enabling cosmetic products to circulate freely in the single market and if the specific objectives have been achieved.
- Efficiency: Evaluate the main benefits and costs of the implementation of the Regulation.
- Relevance: Evaluation of the Regulation, to ensure that it can meet current needs or is outdated, including in the context of the green and digital transitions and the competitiveness of the EU industry, also if its scope is appropriate or needs to be extended to also cover the environmental effects of chemicals in cosmetics. The current rules need to be evaluated to be sufficient to ensure the safety of products for both consumers and professionals
- Coherence: The Regulation needs to be internally consistent and align with other chemicals legislations, such as CLP, REACH, Detergents, Biocides and Medical Devices, to protect EU consumers.
- EU “added value”: Could the objectives of the Regulation have been addressed at the national level only? Or is EU-level legislation on cosmetics necessary?
The evaluation will investigate, among other things, the current scope of the Regulation, the definitions used, the application of the generic risk approach to ingredients with potentially higher risk for human health, and labelling provisions, as well as the main trends in international trade and the external competitiveness of the EU industry.
Why is the EU Commission consulting?
The public consultation aims to collect information on the functioning of the Cosmetic Products Regulation. Consulting stakeholders will provide valuable information as a basis for this evaluation. The consultation aims to validate the topics and issues covered by the evaluation, gather information, data, views, opinions and experience on the implementation of the Cosmetic Products Regulation (CPR) and the extent to which it has met its objectives, and gather views on the Regulation’s relevance, considering scientific, economic, social and other developments.
All interested parties can participate in the consultation. The Commission will seek feedback from stakeholders, including competent administrations and customs authorities, businesses and industry representatives (including manufacturers of ingredients and cosmetic products), NGOs, individuals/consumers, consumer organisations, and others.
The planned completion is Q2 2026.
This call for evidence is open for feedback from the 21st of February 2025 until the 21st of March 2025. After that, the feedback received will be analysed and the expected date to publish the conclusions of the revision is the second quarter of 2026.
Stay Compliant with Cosmeservice
The evaluation of the Cosmetic Products Regulation is a key step in ensuring that the legislation continues to meet its objectives and adapts to the evolving needs of the industry. At Cosmeservice, we stay up to date with regulatory changes to help you navigate compliance with confidence. Trust us to guide your cosmetic products through the EU market with expert support. Get in touch with us today!
